High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
View ORCID ProfileJuan Macías, Ana Pinilla, Francisco A. Lao-Dominguez, Anaïs Corma, Enrique Contreras-Macias, Alejandro González-Serna, Antonio Gutierrez-Pizarraya, Marta Fernández-Fuertes, Ramón Morillo-Verdugo, Marta Trigo, Luis M. Real, Juan A. Pineda
doi: https://doi.org/10.1101/2020.07.30.20165027
Juan Macías
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
MD, PhDAna Pinilla
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
RPHFrancisco A. Lao-Dominguez
2Pharmacy, Hospital Universitario Virgen de Valme. Seville. Spain
PharmDAnaïs Corma
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
MDEnrique Contreras-Macias
2Pharmacy, Hospital Universitario Virgen de Valme. Seville. Spain
PharmDAlejandro González-Serna
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
PhDAntonio Gutierrez-Pizarraya
2Pharmacy, Hospital Universitario Virgen de Valme. Seville. Spain
PharmDMarta Fernández-Fuertes
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
Ramón Morillo-Verdugo
2Pharmacy, Hospital Universitario Virgen de Valme. Seville. Spain
PharmDMarta Trigo
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
MDLuis M. Real
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
PhDJuan A. Pineda
1Infectious Diseases and Microbiology Unit, Hospital Universitario Virgen de Valme. Seville. Spain
MD, PhDData Availability
All data is reported in the paper
Posted August 01, 2020.
High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
Juan Macías, Ana Pinilla, Francisco A. Lao-Dominguez, Anaïs Corma, Enrique Contreras-Macias, Alejandro González-Serna, Antonio Gutierrez-Pizarraya, Marta Fernández-Fuertes, Ramón Morillo-Verdugo, Marta Trigo, Luis M. Real, Juan A. Pineda
medRxiv 2020.07.30.20165027; doi: https://doi.org/10.1101/2020.07.30.20165027
High rate of major drug-drug interactions of lopinavir-ritonavir for COVID-19 treatment
Juan Macías, Ana Pinilla, Francisco A. Lao-Dominguez, Anaïs Corma, Enrique Contreras-Macias, Alejandro González-Serna, Antonio Gutierrez-Pizarraya, Marta Fernández-Fuertes, Ramón Morillo-Verdugo, Marta Trigo, Luis M. Real, Juan A. Pineda
medRxiv 2020.07.30.20165027; doi: https://doi.org/10.1101/2020.07.30.20165027
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (651)
- Anesthesia (174)
- Cardiovascular Medicine (2515)
- Dermatology (210)
- Emergency Medicine (386)
- Epidemiology (11993)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3913)
- Geriatric Medicine (367)
- Health Economics (654)
- Health Informatics (2528)
- Health Policy (973)
- Hematology (351)
- HIV/AIDS (813)
- Medical Education (387)
- Medical Ethics (106)
- Nephrology (418)
- Neurology (3669)
- Nursing (205)
- Nutrition (547)
- Oncology (1910)
- Ophthalmology (555)
- Orthopedics (230)
- Otolaryngology (299)
- Pain Medicine (243)
- Palliative Medicine (71)
- Pathology (465)
- Pediatrics (1076)
- Primary Care Research (435)
- Public and Global Health (6346)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (334)
- Surgery (426)
- Toxicology (51)
- Transplantation (180)
- Urology (156)